SCHEMBL22650374

SCHEMBL22650374

N#CC1CCN(Cc2ccc(N)nc2)CC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACHE P22303 3/20 0.45
▸ CHEK1 O14757 1/20 0.45
▸ LTA4H P09960 3/20 0.45
▸ SSTR5 P35346 1/20 0.41
▸ JAK2 O60674 2/20 0.39
▸ JAK1 P23458 1/20 0.39
▸ KMT2A Q03164 2/20 0.38
▸ HRH3 Q9Y5N1 2/20 0.36
▸ GABRP O00591 1/20 0.36
▸ GABRD O14764 1/20 0.36
▸ GABRA1 P14867 1/20 0.36
▸ GABRB1 P18505 1/20 0.36
▸ GABRG2 P18507 1/20 0.36
▸ GABRB3 P28472 1/20 0.36
▸ GABRA5 P31644 1/20 0.36
▸ GABRA3 P34903 1/20 0.36
▸ GABRA2 P47869 1/20 0.36
▸ GABRB2 P47870 1/20 0.36
▸ GABRA4 P48169 1/20 0.36
▸ GABRE P78334 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22650378 0.92 L3MBTL3 (0.40) ACHECHEK1LTA4HSSTR5KMT2A
SCHEMBL18291465 0.82 HRH3 (0.46) ACHECHEK1LTA4HSSTR5KMT2A
SCHEMBL2231495 0.81 HRH3 (0.58) ACHELTA4HSSTR5KMT2AHRH3
SCHEMBL13768892 0.81 ALDH1A1 (0.50) ACHELTA4HSSTR5KMT2AHRH3
SCHEMBL1587073 0.80 ALDH1A1 (0.56) ACHECHEK1LTA4HJAK2JAK1
SCHEMBL19231861 0.80 ALDH1A1 (0.46) KMT2AHRH3MEN1
SCHEMBL20203525 0.80 ACHE (0.43) ACHECHEK1LTA4HJAK2JAK1
SCHEMBL20037557 0.79 LTA4H (0.42) LTA4HSSTR5KMT2AHRH3GABRP
SCHEMBL18291525 0.78 HRH3 (0.48) ACHELTA4HSSTR5KMT2AHRH3
SCHEMBL1035345 0.78 ALDH1A1 (0.56) HRH3GABRPGABRDGABRA1GABRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020224568-A1 CDK INHIBITORS QILU REGOR THERAPEUTICS INC. (CN) 2020-11-12 — — WO disclosed
Send feedback